<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11539">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01831206</url>
  </required_header>
  <id_info>
    <org_study_id>438/55</org_study_id>
    <nct_id>NCT01831206</nct_id>
  </id_info>
  <brief_title>Collagen Cross-linking in Infectious Keratitis Trial</brief_title>
  <official_title>Collagen Cross-linking in Infectious Keratitis Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <authority>Thailand: Research Institute for Health Sciences</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of collagen cross-linking for
      treatment of infectious keratitis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>decrement of infiltration size</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>decrement of infiltration size between day0 and day 30</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of participants with adverse events</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>adverse events after corneal collagen cross-linking (report in descriptive study)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Infectious Keratitis</condition>
  <condition>Bacterial Keratitis</condition>
  <condition>Fungal Keratitis</condition>
  <arm_group>
    <arm_group_label>Collagen cross-linking</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Collagen cross-linking with standard treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard treatment alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Collagen cross-linking</intervention_name>
    <description>Collagen cross-linking arm will receive standard medication for corneal ulcer treatment and corneal collagen cross-linking.
Standard treatment arm will receive only standard medication.</description>
    <arm_group_label>Collagen cross-linking</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Evidence of corneal ulcer grade II or III (bacteria or fungal, or presumed bacterial
             or fungal)

          -  Age more than 6 year

          -  Patients can understand and can follow the study protocol

        Exclusion Criteria:

          -  Pregnancy by history or urine test

          -  Evidence of herpetic keratitis

          -  Evidence of corneal perforation

          -  Evidence of autoimmune disease

          -  Known allergy to study medication
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ngamjit Kasetsuwan, MD</last_name>
    <phone>+6622564142</phone>
    <email>ngamjitk@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vannarut Satitpitakul, MD</last_name>
    <phone>+6622564142</phone>
    <email>jaijaimail@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ophthalmology department, King Chulalongkorn Memorial hospital</name>
      <address>
        <city>Pratumwan</city>
        <state>Bangkok</state>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ngamjit Kasetsuwan, MD</last_name>
      <phone>+6622564142</phone>
      <email>ngamjitk@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ngamjit Kasetsuwan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 10, 2013</lastchanged_date>
  <firstreceived_date>April 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Ngamjit Kasetsuwan</investigator_full_name>
    <investigator_title>Associated professor</investigator_title>
  </responsible_party>
  <keyword>corneal ulcer</keyword>
  <keyword>keratitis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infection</mesh_term>
    <mesh_term>Keratitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
